Valproate or olanzapine add-on to lithium: An 8-week, randomized, open-label study in Italian patients with a manic relapse

Journal of Affective Disorders

Volumn 99, Issue 1-3, 2007, Pages 247-251

  Maina, Giuseppe ^a   Albert, Umberto ^a   Salvi, Virginio ^a   Mancini, Michele ^b   Bogetto, Filippo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Medical Department   (Italy)

Author keywords

Bipolar disorder; Lithium; Olanzapine; Relapse of mania; Valproate

Indexed keywords

LITHIUM; OLANZAPINE; VALPROIC ACID;

ADD ON THERAPY; ADULT; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; HYPOMANIA; ITALY; MALE; MANIA; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RELAPSE; REMISSION; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; TREATMENT OUTCOME; TREATMENT RESPONSE; TREMOR; WEIGHT GAIN; YOUNG MANIA RATING SCALE;

ADULT; AGED; ANTICONVULSANTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM CARBONATE; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; TREATMENT OUTCOME; VALPROIC ACID;

EID: 33847043974     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2006.09.007     Document Type: Article

References (25)

1. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am. J. Psychiatry 159 4 suppl (2002) 1-50
2. Berk M., Ichim L., and Brook S. Olanzapine compared to lithium in mania: a double-blind randomized controlled trial. Int. Clin. Psychopharmacol. 14 (1999) 339-343
3. Bowden C.L., Brugger A.M., Swann A.C., Calabrese J.R., Janicack P.G., Petty F., Dilsaver S.C., Davis J.M., Rush A.J., Small J.G., Garza-Trevino E.S., Rish S.C., Goodnick P.J., Morris D.D., and for the Depakote Mania Study Group. Efficacy of divalproex versus lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 271 (1994) 918-924 (Erratum in: JAMA 1994; 271: 1830)
4. Findling R.L., McNamara N.K., Gracious B.L., Youngstrom E.A., Stansbrey R.J., Reed M.D., Demeter C.A., Branicky L.A., Fisher K.E., and Calabrese J.R. Combination lithium and divalproex sodium in pediatric bipolarity. J. Am. Acad. Child Adolesc. Psych. 42 (2003) 895-901
5. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for the Diagnostic and Statistical Manual, Fourth Edition, Patient Version (1997), American Psychiatric Press, Washington, DC
6. Freeman M.P., and Stoll A.L. Mood-stabilizers combinations: a review of safety and efficacy. Am. J. Psychiatry 155 (1998) 12-21
7. Goodwin G.M. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J. Psychopharmacol. 17 (2003) 149-173
8. Grunze H., Kasper S., Goodwin G., Bowden C.L., Baldwin D., Licht R.W., Vieta E., Moeller H.J., and WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. World Federation of Societies of Biological Psychiatry, WFSBP guidelines for biological treatment of bipolar disorders: part II. Treatment of mania. World J. Biol. Psychiatry 4 (2003) 5-13
9. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept of Health, Education and Welfare Publication (ADM) 76-338 (1976), National Institute of Mental Health, Rockville, Md 218-222
10. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
11. Keck P.E., Perlis R.H., Otto M.W., Carpenter D., Roth R., and Docherty J.P. The expert consensus guidelines series: treatment of bipolar disorder 2004. Postgrad. Med. Special Report (2004) 1-120 December
12. Pope Jr. H.G., McElroy S.L., Keck P.E., and Hudson J.I. Valproate in the treatment of acute mania: a placebo-controlled study. Arch. Gen. Psychiatry 48 (1991) 62-68
13. Reischies F.M., Hartikainen J., and Berghofer A. Initial lithium and valproate combination therapy in acute mania. Neuropsychobiology 46 suppl 1 (2002) 22-27
14. Sachs G.S., Printz D.J., Kahn D.A., Carpenter D., and Docherty J.P. The expert consensus guideline series: medication treatment of bipolar disorder 2000. Postgrad. Med. Special Report (2000) 1-104 April
15. Schou M. 50 years lithium treatment. Encephale 26 (2000) 1-6 (In French)
16. Suppes T., Dennehy E.B., Swann A.C., Bowden C.L., Calabrese J.R., Hirschfeld R.M., Keck Jr. P.E., Sachs G.S., Crismon M.L., Toprac M.G., Shon S.P., and Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder. Report on the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000. J. Clin. Psychiatry 63 (2002) 288-299
17. Suppes T., Dennehy E.B., Hirschfeld R.M., Altshuler L.L., Bowden C.L., Calabrese J.R., Crismon M.L., Ketter T.A., Sachs G.S., Swann A.C., and for the Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder. The Texas Implementation of Medication Algorithms: update to the algorithms for treatment of bipolar I disorder. J. Clin. Psychiatry 66 (2005) 870-886
18. Tohen M., Sanger T.M., McElroy S.L., Tollefson G.D., Chengappa K.N., Daniel D.G., Petty F., Centorrino F., Wang R., Grundy S.L., Greaney M.G., Jacobs T.G., David S.R., and Toma V. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am. J. Psychiatry 156 (1999) 702-709
19. Tohen M., Jacobs T.G., Grundy S.L., McElroy S.L., Barrov M.C., Janicak P.G., Sanger T., Risser R., Zhang F., Toma V., Francis J., Tollefson G.D., and Breier A. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group. Arch. Gen. Psychiatry 57 (2000) 841-849 (Erratum in: Arch. Gen. Psychiatry 2002; 59: 91)
20. Tohen M., Chengappa K.N., Suppes T., Zarate Jr. C.A., Calabrese J.R., Bowden C.L., Sachs G.S., Kupfer D.J., Baker R.W., Risser R.C., Keeter E.C., Feldman P.D., Tollefson G.D., and Breier A. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch. Gen. Psychiatry 59 (2002) 62-69
21. Tohen M., Baker R.W., Altshuler L.L., Zarate C.A., Suppes T., Ketter T.A., Milton D.R., Risser R., Gilmore J.A., Breier A., and Tollefson G.A. Olanzapine versus divalproex in the treatment of acute mania. Am. J. Psychiatry 159 (2002) 1011-1017 (Erratum in: Am. J. Psychiatry. 2005; 7: 102)
22. Yatham L.N., Kennedy S.H., O'Donovan C., Parikh S., MacQueen G., McIntyre R., Sharma V., Silrverstone P., Alda M., Baruch P., Beaulieu S., Daigneault A., Milev R., Young T., Ravindrau A., Schaffer A., Connolly M., and Gorman C.P. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord. 7 3 suppl (2005) 5-69 (Canadian Network for Mood and Anxiety Treatments)
23. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 133 (1978) 429-435
24. Zajecka J.M., Weisler R., Sachs G., Swan A.C., Wozniak P., and Sommerville K.W. A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. J. Clin. Psychiatry 63 (2002) 1148-1155
25. Zarate Jr. C.A., and Quiroz J.A. Combination treatment in bipolar disorder: a review of controlled trial. Bipolar Disord. 5 (2003) 217-225 (Erratum in: Bipolar Disord. 2003; 5:307)